Scarica l'app Stockscreener
5.15
6.70%
-0.37
Dopo l'orario di chiusura:
5.01
-0.14
-2.72%
Precedente Chiudi:
$5.52
Aprire:
$5.41
Volume 24 ore:
14,398
Relative Volume:
0.01
Capitalizzazione di mercato:
$2.95M
Reddito:
$856.00K
Utile/perdita netta:
$-12.56M
Rapporto P/E:
-0.0222
EPS:
-231.4926
Flusso di cassa netto:
$-4.14M
1 W Prestazione:
-12.19%
1M Prestazione:
-51.37%
6M Prestazione:
-57.92%
1 anno Prestazione:
+82.82%
Intervallo 1D:
$5.02
$5.5201
Intervallo di 1 settimana:
$4.8902
$6.1557
Portata 52W:
$2.7234
$80.10
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
5.15 | 3.16M | 856.00K | -12.56M | -4.14M | -231.49 |
VRTX
Vertex Pharmaceuticals Inc
|
498.01 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
624.72 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
909.50 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.67 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
187.51 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Scisparc Ltd Borsa (SPRC) Ultime notizie
NeuroThera Labs Announces C$5,000,000 Private Placement of Units - TheNewswire
SciSparc Company Profile & Introduction - Moomoo
Scisparc Ltd (SPRC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Form 144 SciSparc Ltd. For: 22 June By Investing.com - Investing.com Australia
[144] SciSparc Ltd. SEC Filing - Stock Titan
Scisparc Ltd (SPRC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Scisparc Ltd (SPRC) Institutional Confidence - TradingKey
Scisparc Ltd (SPRC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Scisparc Ltd (SPRC) Valuation: PE, PB & Fair Value Analysis - TradingKey
SPRC News | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
Scisparc Ltd (SPRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Scisparc Ltd (SPRC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Scisparc Ltd (SPRC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scisparc Ltd (SPRC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SPRC Stock Price, Quote & Chart - ChartMill
SciSparc Ltd. Ordinary Shares Stock Short Interest Rises to 66.94% - Moomoo
SciSparc Ltd.'s Equity Buyback announced on July 7, 2022, has expired. - marketscreener.com
Why is SciSparc stock skyrocketing on Thursday? - MSN
SciSparc more than doubles as NeuroThera wins conditional nod for CliniQuantum deal - MSN
NeuroThera completes acquisition of 54% stake in CliniQuantum - Investing.com UK
In today's session, these stocks are experiencing unusual volume. - ChartMill
Which stocks are gapping on Thursday? - ChartMill
SPRC Stock Pops As SciSparc Pushes Into Quantum Clinical Analytics - timothysykes.com
SciSparc Subsidiary NeuroThera Labs Closes Majority Acquisition of CliniQuantum - TipRanks
These stocks that are showing activity before the opening bell on Thursday. - ChartMill
NeuroThera completes acquisition of 54% stake in CliniQuantum By Investing.com - Investing.com India
SciSparc (NASDAQ: SPRC) unit NeuroThera acquires 54% of CliniQuantum in CAD$9.46M share deal - Stock Titan
Quantum trial-analysis startup CliniQuantum sold in C$9.5M SciSparc deal - Stock Titan
SciSparc Ltd. Subsidiary NeuroThera Labs Inc. Completes Acquisition of 54% Stake in CliniQuantum Ltd. - Quiver Quantitative
NeuroThera Labs Inc. Announces Closing of Acquisition of Majority Stake in CliniQuantum Ltd. - Yahoo Finance
Neurothera Labs Inc. Announces Closing Of Acquisition Of Majority Stake In Cliniquantum Ltd. - marketscreener.com
SciSparc's Quantum Gambit: Betting on AI to Remake Drug Trials - BriefGlance
Director Itschak Shrem Sells Shares of SciSparc Ltd (SPRC) - GuruFocus
SciSparc (SPRC) director Itschak Shrem sells 462 Ordinary Shares at $10 - Stock Titan
SciSparc Shares Jumped Last Week, Market Awaits Monday Deal Deadline - Bez Kabli
SciSparc Subsidiary Wins Conditional TSXV Nod for CliniQuantum Acquisition, Amends Deal Terms - TipRanks
SciSparc (Nasdaq: SPRC) unit to buy 54% of CliniQuantum in share deal - Stock Titan
SciSparc stock surges 200% on NeuroThera acquisition progress - Investing.com
Top Biotech Gainers: SPRC Deal Gets Nod, CODX Rallies, OTLK, AKTX, FTRE Drawing Investor Interest - RTTNews
SciSparc Ltd. (SPRC) Stock: Shares Soar 202% on NeuroThera’s TSX Approval - MEXC
SciSparc stock surges 157% after subsidiary gets conditional TSX approval for major acquisition - Pluang
SciSparc Ltd. (SPRC) Stock Explodes 202% Following NeuroThera’s TSX Exchange Milestone - MEXC
SciSparc Jumps 150.8% as Subsidiary Wins Conditional Exchange Approval for CliniQuantum Deal - Moomoo
SciSparc jumps 150.8% as subsidiary wins conditional exchange approval for CliniQuantum deal - Quiver Quantitative
Why Is SciSparc Stock Skyrocketing On Thursday? - Benzinga
SciSparc Ltd. (SPRC) Stock Explodes 202% Following NeuroThera's TSX Exchange Milestone - Blockonomi
SciSparc (SPRC) Stock Rockets 202% as NeuroThera Gets TSX Green Light - MoneyCheck
Scisparc Ltd Azioni (SPRC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):